Recent Updates
Recently added Catalysts
STAA Positive Sentiment

Verbraucherumfrage von STAAR Surgical: 71 Prozent der Deutschen möchten auf Sehhilfen verzichten, kennen aber ihre Alternativen nicht

Monday, September 28, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: STAAR Surgical released findings from a global consumer survey on vision correction. In Germany, 1,000 adults were surveyed, revealing that 71% prefer to avoid vision aids but lack knowledge about alternatives. This indicates a potential market for educating consumers on refractive surgery options.

Market Sentiment Analysis

POSITIVE FACTORS

  • 71% of Germans prefer to avoid vision aids.
  • Increased awareness of alternatives to vision correction.
  • Positive outlook on the future of refractive surgery.

Full Press Release Details

HAMBURG, Germany--(BUSINESS WIRE)--Die STAAR Surgical Company, weltweit führender Anbieter von phakischen Intraokularlinsen mit der EVO™-Produktfamilie implantierbarer Collamer®-Linsen (EVO ICL™) zur Sehkorrektur, hat die Ergebnisse ihrer globalen Verbraucherumfrage zur Zukunft der refraktiven Chirurgie veröffentlicht. In sieben Märkten wurde die Einstellung der Verbraucher zum Thema Sehkorrektur untersucht. In Deutschland wurden im März 2026 insgesamt 1.000 Erwachsene befragt. Das Ergebnis: Ve

Frequently Asked Questions

What percentage of Germans want to avoid vision aids?

71% of Germans prefer to avoid using vision aids.

How many adults were surveyed in Germany?

1,000 adults were surveyed in Germany.

What is the focus of STAAR Surgical's survey?

The survey focuses on consumer attitudes towards vision correction.

What product family is associated with STAAR Surgical?

The EVO™ product family of implantable Collamer® lenses.

ShareAdd on Google
Tags: STAA Viatris Investor Conferences Healthcare STAAR Surgical vision correction Germany EVO ICL refractive surgery
Last updated: Sep 28, 2026

Biotech snapshot

Cash runway
$181M liquidity · $0M/mo burn
Low dilution risk